Beatty Lab

Unofficial twitter of the Beatty Lab. Managed by his mischievous lab members. Home of the #ShitGregorySays series!

[Beatty Lab @LabBeatty]

🎉 Congratulations to @JPlesset on defending her thesis! We’re so proud of your hard work and dedication. Excited to see what’s next for you! 🥳👏

[CAMB Graduate Group @CAMBUpenn]

Jacqueline Plesset (@JPlesset) in the @LabBeatty defends her thesis tomorrow!

[Beatty Lab @LabBeatty]

Gregory’s alter ego, Grego, is getting into the holiday spirit! 🦖🎄

[Beatty Lab @LabBeatty]

Can you guess which tray of cupcakes was decorated by a 4th grader and which by a 6th grader? 🧁 There’s a bigger picture hiding in the first picture's tray… can you spot it? 👀🔍#CupcakeConundrum

[Beatty Lab @LabBeatty]

OoooOooh. Look who’s back 👀 @jesse_lee3

[Eric Topol @EricTopol]

The liver can be a path towards establishing immune tolerance for autoimmune diseases. But it also promotes immune evasion of cancer. A mechanism for this is identified here and could prove useful for directing therapy
https://t.co/T4kdZs83q8
@NatImmunol @LabBeatty @PennMedicine

[Beatty Lab @LabBeatty]

“Maybe I should give it as an analogy… IDK, I have been thinking about dogs lately. Maybe it bifurcated into a frenchie or shorkie… Like a shih tzu and a Yorkie.”

#shitgregorysays

[Beatty Lab @LabBeatty]

Happy Solar Eclipse Day!🌘

For anyone that missed the eclipse or didn’t have eye protection to view it, enjoy these pics our newest undergrads were able to capture:

[Beatty Lab @LabBeatty]

“When you leave the house you never leave the home @jesse_lee3 “

#ShitGregorySays

[Beatty Lab @LabBeatty]

“It's not as fun as flipping it on, flipping it off, flipping it on, flipping it off, flipping it on, flipping it off, flipping it on, flipping it off, flipping it on, flipping it off, like a light switch”💡-Gregory Beatty
#ShitGregorySays

[Penn Medicine @PennMedicine]

“We hope to provide a roadmap to overcome the barriers that prevent #immunotherapy from penetrating throughout the tumor microenvironment and attacking #cancer cells,” said Dr. Gregory Beatty, on his work to improve immunotherapy for #PancreaticCancer. https://t.co/9I05m13r3E

[Penn Medicine CSO @PennMedCSO]

Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice ft. Stacy Thomas, @mmwatt02, @shaantichoibose, Heather Coho, Christopher Cassella, Meredith Stone, Dhruv Patel, Kelly Markowitz, Devora Delman & @LabBeatty https://t.co/9i48SmnZ8O

[Beatty Lab @LabBeatty]

@DrJashDatta @anna_bianchi22 @HalehAmirian @karthik_raj25 @AndrewMarkAdams @DrEMDickey @MarysiaMartos @SylvesterCancer @umiamimedicine Congrats!!

P.S. Is that an EAGLES fan in your group?! LETS GO BIRDS

[@PennMedBenchmarks @PennMedBench]

Here's some insight from @mmwatt02's on his latest work in @SciImmunology which found a potential approach to improve immunotherapy in #pancreaticancer. @PennCancer @LabBeatty https://t.co/CfcCoGw5FJ

[ACIR @ACIR_org]

Targeting CD40 and Dectin-1 in tumoral macrophages in pancreatic cancer. Read our digest and interview with @mmwatt02 here 👉 https://t.co/pB4NaCTckV  @Penn_CBIO  @LabBeatty

[Beatty Lab @LabBeatty]

Whoooo we're done!! And with that...I will soon be handing the control of this twitter to yet another mischievous @LabBeatty member. It's been a pleasure memeing with you all the last couple of years, and hopefully I'll meet you out there in the field!
Best,
(Dr.) @jesse_lee3

[CAMB Graduate Group @CAMBUpenn]

Jesse Lee from the Beatty Lab defends tomorrow!
@LabBeatty

[Anirban Maitra @Aiims1742]

#OpenAccess in @SciImmunology from @LabBeatty @mmwatt02
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
https://t.co/OJExYhACL5
How to co-opt the anti-tumor functions of myeloid cells in #PancreaticCancer through complementary pathways.

[Beatty Lab @LabBeatty]

What's this? Is it a bird? Is it a plane? No!! It's @mmwatt02's work hot off the (digital) presses!

He took some myeloid treatment and some other myeloid treatment thingy...something something...cured cancer...through some mechanism. Go read it NOW!!

https://t.co/A4xUY6n47P

[Science Immunology @SciImmunology]

Combining two treatments that activate myeloid cells may prove successful against tumors where conventional T cell-based immunotherapies have failed, indicates new research in mouse models of pancreatic cancer. @mmwatt02 @LabBeatty @PennMedicine

📄: https://t.co/8D58BXIGLH